Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX)

CUSIP: 14161W105

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock, par value $0.0001
Shares outstanding
53,041,500
Total 13F shares
33,306,573
Share change
+435,808
Total reported value
$1,831,644,508
Put/Call ratio
356%
Price per share
$54.98
Number of holders
148
Value change
+$20,984,402
Number of buys
77
Number of sells
75

Quarterly Holders Quick Answers

What is CUSIP 14161W105?
CUSIP 14161W105 identifies CDLX - Cardlytics, Inc. - Common Stock, par value $0.0001 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q1 2022

As of 31 Mar 2022, Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) was held by 148 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 33,306,573 shares. The largest 10 holders included CAS Investment Partners, LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., JPMORGAN CHASE & CO, 683 Capital Management, LLC, Alua Capital Management LP, KPS Global Asset Management UK Ltd, BAILLIE GIFFORD & CO, and JS Capital Management LLC. This page lists 148 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.